Trial Profile
Proof-of-pharmacology clinical trial on a vaccine that elicits a protective humoral immune response against oxidized low density lipoprotein
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Mar 2018
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 03 Mar 2018 Status changed from recruiting to completed.
- 27 Apr 2016 New trial record